Rossari Biotech Reports Record Q4 Revenue, Eyes Debt-Free Goal

Rossari Biotech has reported a strong finish to FY26, with a record fourth quarter revenue of Rs 684.9 crore, an 18% increase year-on-year. For the full fiscal year, revenue grew 15% to Rs 2,396.4 crore, while EBITDA reached Rs 286 crore.

The company is strategically shifting its focus from volume-based growth to value-driven profitability. A key part of this strategy involves reallocating capital expenditure towards higher-margin segments, specifically pharma and aroma chemicals. Rossari Biotech also plans to divest non-core assets to optimize its operations and aims to become debt-free within 18 months, significantly enhancing its financial flexibility.

This strategic pivot is supported by operational expansions. The company recently commissioned its fully expanded ethoxylation capacity to 66,000 MTPA at its Dahej facility, a significant move to meet growing demand. A new centralized Research and Development facility in Navi Mumbai has also been established to drive innovation. Rossari Biotech is also implementing SAP S/4HANA to improve business integration and decision-making.

Despite these positive developments, raw material costs have presented a challenge. Management noted significant price increases in March, which impacted the standalone EBITDA margin to 11.3% in Q4 FY26, although some of these costs were passed on in April. Geopolitical tensions and subdued demand in certain segments also add to market volatility. The company's loss-making B2C business is targeted for breakeven in FY27.

For fiscal year 2027, Rossari Biotech's management is guiding for at least 15% revenue growth and EBITDA margins expected to be between 12% and 13%.

Investors will be tracking the company's progress on its debt-free target, the turnaround of its B2C segment, and the performance of its higher-margin chemical divisions. The effectiveness of asset divestments and the company's ability to navigate raw material price fluctuations will also be key indicators.

Rossari Biotech operates within a competitive specialty chemicals landscape. Its peers include SRF Ltd, known for diversified chemical and textile operations; Vinati Organics Ltd, a leader in niche products; and Clean Science and Technology Ltd, focused on performance chemicals and pharma intermediates using green chemistry. PI Industries is also a notable player with its agrochemical and growing pharmaceutical segments.